Hologic to Release Third Quarter Fiscal 2009 Operating Results on Monday, August...

Hologic to Release Third Quarter Fiscal 2009 Operating Results on Monday,
August 3, 2009

BEDFORD, Mass., July 13 /PRNewswire-FirstCall/ -- Hologic, Inc. (Hologic or
the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of
premium diagnostics, medical imaging systems and surgical products dedicated
to serving the healthcare needs of women, today announced plans to release its
third quarter fiscal 2009 operating results on Monday, August 3, 2009 after
market close. In conjunction with the release, management will host a
conference call on Monday, August 3, 2009 at 5:00 p.m. (eastern).

Interested participants may listen to the call by dialing 877-719-9795 or
719-325-4836 for international callers and referencing code 3579474
approximately 15 minutes prior to the call on August 3rd. For those unable to
participate in the live broadcast, a replay will be available one hour after
the call ends through Friday, August 14, 2009 at 888-203-1112 or 719-457-0820
for international callers, access code 3579474.

The Company will also provide a live webcast of the call. Interested
participants may access the webcast at the Company's website at
www.hologic.com. A replay of the call will be archived on the Company's
website.

About Hologic, Inc.
Hologic, Inc. is a leading developer, manufacturer and supplier of premium
diagnostics products, medical imaging systems and surgical products dedicated
to serving the healthcare needs of women. Hologic's core business units are
focused on breast health, diagnostics, GYN surgical, and skeletal health.
Hologic provides a comprehensive suite of technologies with products for
mammography and breast biopsy, radiation treatment for early-stage breast
cancer, cervical cancer screening, treatment for menorrhagia, permanent
contraception, osteoporosis assessment, preterm birth risk assessment, mini
C-arm for extremity imaging and molecular diagnostic products including
reagents for a variety of DNA and RNA analysis applications. For more
information, visit www.hologic.com.

Contact: Deborah R. Gordon
Vice President, Investor Relations
Hologic, Inc.
(781) 999-7716

SOURCE Hologic, Inc.

Deborah R. Gordon, Vice President, Investor Relations of Hologic, Inc.,
+1-781-999-7716